MAASH Raises €12.15M and Names Ex-ENOUGH Executive Samah Garringer as CEO

Belgian fermentation company MAASH has secured a €12.15 million financing package to scale up its mycoprotein ingredient production. The funding includes a €5.85 million equity raise with new investors such as Ambra Capital, InvestPro, Bpifrance Amorçage Industriel, and sugar producers Nordzucker and Tereos. Additionally, a €4.3 million investment from Bpifrance and a €2 million loan will support the expansion of a demonstration plant in France.

To lead the industrial phase, MAASH has appointed Samah Garringer, a seasoned executive with experience in food, ingredients, nutrition, and industrial scale-up. The company's acquisition of a fermentation site from Metex Noovista in 2024 has accelerated its path to large-scale mycoprotein production. With Garringer as CEO, MAASH aims to leverage its partnerships and resources to advance its technical and commercial scale-up efforts under the leadership of co-founders Gaspard Gilbert and Frédéric Van Gansberghe.